From autoimmune inflammation to malignancy: causal genetic evidence for the RA-squamous cell lung cancer axis.

Researchers investigated whether rheumatoid arthritis (RA) increases the risk of developing lung cancer, focusing specifically on different types of lung cancer. Using two complementary approaches—a clinical study of nearly 9,000 Chinese patients and genetic analysis of over 92,000 European individuals—they discovered that RA specifically raises the risk of squamous cell lung cancer, but not other lung cancer types like adenocarcinoma or small cell carcinoma. In the Chinese cohort, RA patients had more than double the risk of developing squamous cell lung cancer compared to matched controls. Importantly, the genetic study revealed that smoking had been masking this relationship in previous research; when researchers accounted for smoking's effects, they confirmed that RA itself directly contributes to squamous cell lung cancer risk. For patients with rheumatoid arthritis considering integrative care approaches, this finding emphasizes the importance of lung health monitoring as part of comprehensive treatment. While acupuncture is commonly used to help manage RA symptoms like joint pain and inflammation, patients with RA should work closely with their healthcare team to ensure appropriate lung cancer screening, particularly for the squamous cell subtype. The study supports implementing targeted screening protocols for RA patients at higher risk. If considering acupuncture for RA symptom management, seek a licensed acupuncturist experienced in treating autoimmune and inflammatory conditions.

This triangulated evidence study examined RA-lung cancer associations using propensity-matched cohort analysis (N=8,867 Chinese subjects, 4,661 RA patients, 2014-2024) and multivariable Mendelian randomization with European GWAS data (RA N=92,044; squamous cell lung cancer N=63,053). Clinical findings demonstrated RA specifically increased squamous cell lung cancer risk (adjusted OR=2.415, 95% CI: 1.104-5.283, P=0.027) but not adenocarcinoma (P=0.437) or small cell carcinoma (P=0.564). Machine learning prediction models showed limited utility (AUC=0.57-0.68). Crucially, multivariable MR analysis adjusting for smoking genetics revealed causal promotion (OR=1.02, 95% CI: 1.00-1.04, P=0.046), resolving the apparent protective effect seen in univariable analysis. Clinical implication: RA patients warrant targeted squamous cell lung cancer surveillance. Practitioners treating RA with acupuncture and integrative approaches should ensure patients receive appropriate pulmonary screening and coordinate care accordingly.